c-Src inhibitor selectively inhibits triple-negative breast cancer overexpressed Vimentin in vitro and in vivo
出版年份 2018 全文链接
标题
c-Src inhibitor selectively inhibits triple-negative breast cancer overexpressed Vimentin in vitro and in vivo
作者
关键词
-
出版物
CANCER SCIENCE
Volume 109, Issue 5, Pages 1648-1659
出版商
Wiley
发表日期
2018-03-26
DOI
10.1111/cas.13572
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
- (2017) Carsten Denkert et al. LANCET
- The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl
- (2016) Jennifer L. Dine et al. BREAST CANCER RESEARCH AND TREATMENT
- Impact of Expression of Vimentin and Axl in Breast Cancer
- (2016) Kimihiro Tanaka et al. Clinical Breast Cancer
- UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer
- (2016) R. A. Gilani et al. CLINICAL CANCER RESEARCH
- Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis
- (2016) Ami Patel et al. LIFE SCIENCES
- Targeting Src in endometriosis-associated ovarian cancer
- (2016) R Manek et al. Oncogenesis
- Vimentin–ERK Signaling Uncouples Slug Gene Regulatory Function
- (2015) Reetta Virtakoivu et al. CANCER RESEARCH
- Design, Synthesis, and Structure–Activity Relationship Studies of 3-(Phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine Derivatives as a New Class of Src Inhibitors with Potent Activities in Models of Triple Negative Breast Cancer
- (2015) Chun-Hui Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cyr61 as mediator of Src signaling in triple negative breast cancer cells
- (2015) María Pilar Sánchez-Bailón et al. Oncotarget
- Transmembrane-Bound IL-15–Promoted Epithelial-Mesenchymal Transition in Renal Cancer Cells Requires the Src-Dependent Akt/GSK-3β/β-Catenin Pathway
- (2015) Huaqin Yuan et al. NEOPLASIA
- Molecularly targeted therapies for metastatic triple-negative breast cancer
- (2013) Soley Bayraktar et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast cancer statistics, 2013
- (2013) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- c-Src Modulates Estrogen-Induced Stress and Apoptosis in Estrogen-Deprived Breast Cancer Cells
- (2013) P. Fan et al. CANCER RESEARCH
- P-cadherin and vimentin are useful basal markers in breast cancers
- (2013) Julia Y.S. Tsang et al. HUMAN PATHOLOGY
- Vimentin DNA methylation predicts survival in breast cancer
- (2012) Jacob Ulirsch et al. BREAST CANCER RESEARCH AND TREATMENT
- Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines
- (2012) Ping Fan et al. EUROPEAN JOURNAL OF CANCER
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers
- (2012) Sohrab P. Shah et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Metastatic Progression of Prostate Cancer and E-Cadherin
- (2011) Aaron P. Putzke et al. AMERICAN JOURNAL OF PATHOLOGY
- Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy
- (2011) M. Campone et al. ANNALS OF ONCOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer
- (2011) Ayca Gucalp et al. Clinical Breast Cancer
- Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study
- (2011) R. S. Finn et al. CLINICAL CANCER RESEARCH
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Vimentin organization modulates the formation of lamellipodia
- (2011) Brian T. Helfand et al. MOLECULAR BIOLOGY OF THE CELL
- Simultaneous siRNA Targeting of Src and Downstream Signaling Molecules Inhibit Tumor Formation and Metastasis of a Human Model Breast Cancer Cell Line
- (2011) Jeffrey D. Bjorge et al. PLoS One
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biology, Metastatic Patterns, and Treatment of Patients with Triple-Negative Breast Cancer
- (2009) Carey K. Anders et al. Clinical Breast Cancer
- Search for New Treatments Intensifies for Triple-Negative Breast Cancer
- (2009) Vicki Brower JNCI-Journal of the National Cancer Institute
- Targeting Src in breast cancer
- (2008) R. S. Finn ANNALS OF ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation